September 27, 2016 / 12:57 PM / a year ago

BRIEF-BioNap consulting's Jason Napodano issues an update on BriaCell Therapeutics

Sept 27 (Reuters) - Briacell Therapeutics Corp

* BioNap consulting’s Jason Napodano issues an update on BriaCell Therapeutics Corp

* Expects to initiate a phase I/IIa program with BriaVax in Q4 of 2016

* Says BriaCell is currently completing final stages of manufacturing of vaccine for clinical study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below